Waters Corporation (NYSE:WAT) Receives $384.33 Average Price Target from Analysts

Shares of Waters Corporation (NYSE:WATGet Free Report) have earned a consensus rating of “Moderate Buy” from the eighteen brokerages that are currently covering the stock, Marketbeat.com reports. Ten equities research analysts have rated the stock with a hold rating, six have given a buy rating and two have assigned a strong buy rating to the company. The average 12-month price objective among brokers that have covered the stock in the last year is $384.3333.

Several brokerages have commented on WAT. Redburn Partners set a $390.00 price target on shares of Waters in a research note on Wednesday, October 8th. Wells Fargo & Company upped their target price on shares of Waters from $315.00 to $385.00 and gave the company an “equal weight” rating in a report on Wednesday, November 5th. Weiss Ratings reiterated a “hold (c)” rating on shares of Waters in a research note on Wednesday, October 8th. Rothschild & Co Redburn started coverage on shares of Waters in a research report on Wednesday, October 8th. They issued a “buy” rating and a $390.00 price target for the company. Finally, Cowen reaffirmed a “hold” rating on shares of Waters in a report on Wednesday, November 5th.

Read Our Latest Analysis on WAT

Waters Stock Performance

NYSE:WAT opened at $394.41 on Wednesday. The firm has a market capitalization of $23.48 billion, a PE ratio of 36.25, a price-to-earnings-growth ratio of 3.59 and a beta of 1.16. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.53 and a quick ratio of 1.08. The business’s fifty day moving average price is $360.46 and its 200 day moving average price is $332.03. Waters has a 12 month low of $275.05 and a 12 month high of $423.56.

Waters (NYSE:WATGet Free Report) last released its quarterly earnings data on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share (EPS) for the quarter. Waters had a return on equity of 36.59% and a net margin of 20.89%.The business had revenue of $608.55 million during the quarter. On average, sell-side analysts anticipate that Waters will post 12.86 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. UMB Bank n.a. boosted its holdings in shares of Waters by 2.8% in the second quarter. UMB Bank n.a. now owns 1,055 shares of the medical instruments supplier’s stock valued at $368,000 after acquiring an additional 29 shares during the period. Integrated Wealth Concepts LLC raised its position in Waters by 2.9% in the 1st quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock valued at $386,000 after purchasing an additional 30 shares during the last quarter. Exchange Traded Concepts LLC boosted its stake in Waters by 5.9% during the 3rd quarter. Exchange Traded Concepts LLC now owns 630 shares of the medical instruments supplier’s stock worth $189,000 after purchasing an additional 35 shares during the period. Penserra Capital Management LLC boosted its stake in Waters by 13.1% during the 2nd quarter. Penserra Capital Management LLC now owns 327 shares of the medical instruments supplier’s stock worth $114,000 after purchasing an additional 38 shares during the period. Finally, Tokio Marine Asset Management Co. Ltd. grew its position in Waters by 1.8% during the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 2,264 shares of the medical instruments supplier’s stock worth $679,000 after purchasing an additional 41 shares during the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

About Waters

(Get Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Read More

Analyst Recommendations for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.